Physician profile
Jayesh K Patel
NPI 1831181080
$1,764.48
in general payments reported to CMS, 2019-2025
21 companies · $409 in 2025
The $409 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $525 · 2020: $193 · 2021: $167 · 2022: $67.68 · 2023: $112 · 2024: $291 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $812.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $812.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $347.22 | 2019-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $237.28 | 2019-2023 | Watchman Access System |
| Corvista Health, INC. | $207.61 | 2025 | Corvista System |
| Medtronic, INC. | $160.49 | 2024 | Micra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $137.50 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $121.78 | 2019-2022 | |
| Medtronic Vascular, INC. | $95.12 | 2019-2020 | |
| Amgen INC. | $77.31 | 2019-2022 | |
| Cardiovascular Systems INC. | $57.00 | 2021 | |
| Sanofi-Aventis U.S. LLC | $55.90 | 2019-2020 | |
| Esperion Therapeutics, INC. | $41.80 | 2021 | |
| Akcea Therapeutics, INC. | $38.23 | 2019 | |
| Amarin Pharma, INC. | $38.21 | 2019 | |
| Elutia, INC. | $37.34 | 2023 | |
| Atricure, INC. | $28.05 | 2025 | Synergy Ablation System |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $19.67 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.19 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.96 | 2019 | |
| Astellas Pharma US INC | $12.56 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.86 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.